Overview

Safety Study in Outpatient Japanese Children With ADHD

Status:
Completed
Trial end date:
2003-10-01
Target enrollment:
Participant gender:
Summary
Evaluate the safety and efficacy of atomoxetine in Japanese pediatric patients with ADHD.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Atomoxetine Hydrochloride